It has been shown in glioma and breast cancer cell lines that CCL2 expression and receptor engagement can increase proliferation and cancer stem cell self-renewal, suggesting direct roles that may benefit tumor cells in PDAC as well [58]. Here, CCL2 is linked to neoplasm.